Ginkgo Bioworks Holdings DNA
NYSE DNA
$6.76 -0.03 (-0.44%)
As of: Sep 10, 2026 · 10:00 AM EDT

Ginkgo Bioworks Holdings (DNA) Property, Plant & Equipment (Net) Growth (3y) (2023 - 2026)

Analysis

Ginkgo Bioworks Holdings (DNA) Property, Plant & Equipment (Net) Growth (3y) (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (3y) (Qtr)
1 Iqvia Holdings 42.38 Bn 40.30 Bn 1.44 Bn 2.36%
2 Medpace Holdings 16.51 Bn 16.01 Bn 201.64 Mn 11.02%
3 Charles River Laboratories International 13.16 Bn 12.97 Bn 452.07 Mn -0.76%
4 Icon 12.39 Bn 11.46 Bn 479.29 Mn 3.61%
5 Fortrea Holdings 1.57 Bn 1.40 Bn 139.20 Mn -9.72%
6 Evotec SE 621.88 Mn 196.00 Mn - -12.68%
7 Ginkgo Bioworks Holdings 419.14 Mn 334.60 Mn 18.44 Mn -18.86%
8 Champions Oncology 71.79 Mn 71.79 Mn 7.03 Mn -21.13%
9 MindWalk Holdings 59.83 Mn 51.55 Mn 1.82 Mn -59.70%
10 VivoSim Labs 1.45 Mn 1.45 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -18.86%
Mar 31, 2026 -19.63%
Dec 31, 2025 -18.99%
Sep 30, 2025 -1.99%
Jun 30, 2025 1.88%
Mar 31, 2025 9.87%
Dec 31, 2024 11.80%
Sep 30, 2024 13.93%
Dec 31, 2023 15.72%